(Q40650298)

22 September 2017

0 references

Protection of neonates and infants by maternal immunization (English)

1 reference

22 September 2017

1

Volker Gerdts

1 reference

PubMed ID

27248694

Sylvia van Drunen Littel-van den Hurk

22 September 2017

series ordinal

2

object named as

Sylvia van Drunen Littel-van den Hurk

1 reference

22 September 2017

Andrew Potter

3

1 reference

22 September 2017

1 June 2016

1 reference

Expert Review of Vaccines

22 September 2017

1 reference

Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis

22 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Innate immunity of the newborn: basic mechanisms and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Maternal antibodies and infant immune responses to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Effectiveness of maternal pertussis vaccination in England: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Maternal immunity provides protection against pertussis in newborn piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Immune responses in infants whose mothers received Tdap vaccine during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1195266

10.1080/14760584.2016.1195266

21 January 2018

Identifiers

DOI

0 references

PubMed ID

27248694

1 reference

PubMed ID

27248694